Biogen Inc (BIIB)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $37.20B
Last updated: Nov 17, 2026 at 4:15 PM ET
Biogen Inc (BIIB) Stock Chart
Biogen (BIIB) has a latest price of $250.79 on Nov 17, 2026, 3.9% below its 52-week high of $261.00. Its price rose 49.7% over the past 12 months. The month-end price fell 9.5% over the 10 years through Oct 2026, a compound annual decline of 1.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $353.49 in Aug 2018 and its lowest $121.08 in Apr 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BIIB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIIB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 13.2%, and over 6 months it rose 31.6%. The month-end price rose 6.8% over the 3 years through Oct 2026, a compound annual rate of 2.2%.
| Period | Change |
|---|---|
| 1 month | +7.4% |
| 3 months | +13.2% |
| 6 months | +31.6% |
| 12 months | +49.7% |
| 12 months, with dividends | +49.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +6.8% | +2.2% |
| 5 years | -4.9% | -1.0% |
| 10 years | -9.5% | -1.0% |
Price by Year
Its best calendar year was 2022, when the price rose 15.4%, and its weakest was 2024, when it fell 40.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $253.62 | +44.1% |
| 2025 | $175.99 | +15.1% |
| 2024 | $152.92 | -40.9% |
| 2023 | $258.77 | -6.6% |
| 2022 | $276.92 | +15.4% |
| 2021 | $239.92 | -2.0% |
| 2020 | $244.86 | -17.5% |
| 2019 | $296.73 | -1.4% |
| 2018 | $300.92 | -5.5% |
| 2017 | $318.57 | +12.3% |
Trading Range
The price is 6.8% above its 50-day average of $234.73 and 21.8% above its 200-day average of $205.87.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $250.79 | |
| 52-week high | $261.00 | -3.9% |
| 52-week low | $160.36 | +56.4% |
| 50-day average | $234.73 | +6.8% |
| 200-day average | $205.87 | +21.8% |
Price Risk
Over 3 years, its largest fall from a peak was 57.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.39 |
| Largest fall, 1 year | -14.3% |
| Largest fall, 3 years | -57.7% |
Valuation
Biogen traded at 11.5x earnings at the end of 2025, against a 5-year median of 12.5x and a 10-year median of 12.4x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BIIB
What is BIIB's 1-year price change?
Biogen's price rose 49.7% over the past 12 months. With dividends included, the 12-month total return was 49.7%.
What is BIIB's 5-year price change?
Biogen's month-end price fell 4.9% over the 5 years through Oct 2026, a compound annual decline of 1.0%. These figures leave out dividends.
What is BIIB's 52-week high and low?
Biogen's 52-week high is $261.00 and its 52-week low is $160.36. Its latest price of $250.79 on Nov 17, 2026 is 3.9% below the high.
What is BIIB's beta?
Biogen's 1-year beta against the S&P 500 is 0.39, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 14.3%.
Is the BIIB chart free?
Yes. Advanced Charting for BIIB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BIIB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors